Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Recruiting · NCT07310446 · Observational (researchers observe without assigning treatment) · Lead sponsor: Universal Diagnostics
View the official record on ClinicalTrials.gov →What this trial is about
This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.
Who can take part
Age range
45 Years to 84 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Arm A: Diagnosed with CRC
- Arm B: Undergoing screening with colonoscopy for CRC
Exclusion criteria
- Arm A: Undergoing treatment for CRC,
- Arm B: Past history of CRC
Where it is running
1 location listed across 1 US state.
- Gastroenterology and Internal Medicine Specialists - Lake Barrington, Illinois, United States